Results 191 to 200 of about 23,969 (235)

Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations. [PDF]

J Ophthalmic Inflamm Infect
Pleyer U, Pavesio C, Miserocchi E, Heinz C, Devonport H, Llorenç V, Burke T, Nogueira V, Kodjikian L, Bodaghi B.   +9 more
europepmc   +1 more source

Infographic: adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II). [PDF]

Eye (Lond)
Crisostomo KGR, Crisostomo KGR, Azarcon CP, Artiaga JCM.   +3 more
europepmc   +1 more source

Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry. [PDF]

Ophthalmol Ther
Tarsia M, Vitale A, Gaggiano C, Sota J, Maselli A, Bellantonio C, Guerriero S, Dammacco R, La Torre F, Ragab G, Hegazy MT, Fonollosa A, Paroli MP, Del Giudice E, Maggio MC, Cattalini M, Fotis L, Conti G, Mauro A, Civino A, Diomeda F, de-la-Torre A, Cifuentes-González C, Tharwat S, Hernández-Rodríguez J, Gómez-Caverzaschi V, Pelegrín L, Babu K, Gupta V, Minoia F, Ruscitti P, Costi S, Breda L, La Bella S, Conforti A, Mazzei MA, Carreño E, Amin RH, Grosso S, Frediani B, Tosi GM, Balistreri A, Cantarini L, Fabiani C.   +43 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Therapies in Development for Non-Infectious Uveitis

Current Molecular Medicine, 2015
Uveitis represents a spectrum of diseases characterized by ocular inflammation that leads to significant visual loss if left untreated. Adequate, long-term control of inflammation with minimal systemic and local adverse effects is the preferred strategy for treating patients with uveitis.
M A, Sadiq, A, Agarwal, M, Hassan, R, Afridi, S, Sarwar, M K, Soliman, D V, Do, Q D, Nguyen   +7 more
openaire   +2 more sources

Cytokines in Immune-mediated “Non-infectious” Uveitis

Klinische Monatsblätter für Augenheilkunde, 2023
AbstractUveitis is a significant cause of ocular morbidity and accounts for approximately 5 – 10% of visual impairments worldwide, particularly among the working-age population. Infections are the cause of ~ 50% cases of uveitis, but it has been suggested that infection might also be implicated in the pathogenesis of immune-mediated “non-infectious ...
Dimitrios Kalogeropoulos, Panagiotis Kanavaros, Georgios Vartholomatos, George Moussa, Soon Wai Chʼng, Chris Kalogeropoulos   +5 more
openaire   +2 more sources

Non-Infectious Pediatric Uveitis

Pediatric Drugs, 2009
Pediatric non-infectious uveitis remains a rare but potentially sight-threatening group of diseases. However, early screening and treatment can improve outcomes. No single agent has proven to be efficacious in all cases. A wide variety of long-term immunomodulatory treatments are available; these agents differ in both their potency and side effect ...
Sharma, Srilakshmi M, Dick, Andrew D, Ramanan, Athimalaipet V   +2 more
openaire   +3 more sources

Uveitis in Sarcoidosis – Clinical Features and Comparison with Other Non-infectious Uveitis

Ocular Immunology and Inflammation, 2022
Comparison of sarcoid uveitis with other non-infectious uveitis treatment and visual outcomes.Retrospective study of 287 eyes with sarcoid uveitis and 1517 eyes with other non-infectious uveitis (15,029 eye-years follow-up).Sarcoid uveitis patients presented at age 43.1 ± 0.8 years, and 66.2% were female.
Rachael L. Niederer, Lazha Sharief, Oren Tomkins-Netzer, Sue L. Lightman   +3 more
openaire   +2 more sources

Smoking complicates the course of non-infectious uveitis

Graefe's Archive for Clinical and Experimental Ophthalmology, 2011
Data concerning the association of smoking and uveitis are limited. The aim of this study was to evaluate the effect of tobacco smoking on uveitis activity and complications of noninfections uveitis and the need for immunosuppressive therapy.We conducted an observational cross-sectional study in 350 patients with noninfectious uveitis.
Roesel, Martin, Ruttig, Anne, Schumacher, Claudia, Heinz, Carsten, Heiligenhaus, Arnd   +4 more
openaire   +2 more sources

Intravitreal immunotherapy in non-infectious uveitis: an update

Expert Review of Clinical Pharmacology, 2023
In the past several years, there have been numerous advances in pharmacotherapeutics for the management of uveitis and other ocular inflammatory diseases, including newer therapeutic agents and ocular drug delivery systems. One of the most attractive modes of drug delivery is the intravitreal route since it has proven to be safe and efficacious and ...
Nitin Kumar, Menia, Sashwanthi, Mohan, Aniruddha, Agarwal   +2 more
openaire   +2 more sources

Optimising drug therapy for non-infectious uveitis

International Ophthalmology, 2018
Uveitis encompasses a wide variety of sight-threatening diseases characterized by intraocular inflammation. It is often classified as infectious and non-infectious uveitis. Unlike infectious uveitis, a distinct infectious agent cannot be identified in non-infectious uveitis and disease origin is usually autoimmune, drug related, or idiopathic.Non ...
Mohammad Ali Shahab, Tahreem Aman Mir, Sidra Zafar   +2 more
openaire   +2 more sources